Related Experiment Videos
Frusemide in respiratory distress syndrome
Archives of Disease in Childhood
|September 1, 1975
Summary
Furosemide did not improve blood gas levels in premature infants with respiratory distress syndrome (RDS). This diuretic significantly increased urine output and electrolyte excretion but is not recommended for routine RDS management.
Area of Science:
- Neonatal Medicine
- Pediatric Pharmacology
- Critical Care
Background:
- Respiratory distress syndrome (RDS) is a common condition in premature infants.
- Management of RDS often involves supportive care and monitoring of physiological parameters.
Purpose of the Study:
- To evaluate the effect of furosemide on urinary output and electrolyte excretion in premature infants with severe RDS.
- To assess the impact of furosemide on blood gas tensions (PaO2 and PaCO2) in infants with RDS.
Main Methods:
- A study was conducted on 7 premature infants with severe RDS who received furosemide.
- Measurements of urinary volume, sodium, and calcium excretion were compared to 13 untreated infants with less severe RDS.
- Blood gas tensions (PaO2 and PaCO2) were monitored in 5 infants receiving furosemide.
Main Results:
- Furosemide administration led to a fourfold increase in urinary volume.
- Urinary sodium and calcium excretion increased tenfold in infants treated with furosemide compared to the control group.
- No significant improvement in blood gas tensions (PaO2 and PaCO2) was observed.
Conclusions:
- Furosemide significantly increases diuresis and electrolyte excretion in premature infants with RDS.
- The use of furosemide does not appear to improve respiratory function as indicated by blood gas levels.
- Routine use of furosemide for managing respiratory distress syndrome in premature infants is not supported by these findings.